Skip to content

RCT-evaluation of Retzius-sparing Robotic Prostatectomy

Robotic Retzius-sparing Radical Prostatectomy- a Randomized Controlled Trial Evaluating Transdouglas-RARP

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03787823
Enrollment
186
Registered
2018-12-26
Start date
2018-08-27
Completion date
2020-11-30
Last updated
2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer, Urinary Incontinence

Brief summary

Prospective randomized blinded RCT comparing Transdouglas Prostatectomy to classical transperitoneal anterior radical prostatectomy

Detailed description

We will evaluate functional urinary and sexual recovery, oncologic outcomes and postoperative complications in patients over a follow up period of 12 months

Interventions

PROCEDURErobotic Prostatectomy (RARP)

Modification of robotic Prostatectomy Arm A classic technique/ anterior transperitoneal RARP Arm B Transdouglas Technique/retzius-sparing RARP

Sponsors

Heidelberg University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Indication for radical prostatectomy * \>18 years old * Literate * Preoperatively continent * informed signed consent for study

Exclusion criteria

* cT4-Cancer * Withdrawl of consent to study

Design outcomes

Primary

MeasureTime frameDescription
Urinary continence1 Week after ProstatectomyPad use

Secondary

MeasureTime frameDescription
Resection marginepathology report, approximately 1 week postoperatively
Urinary continence3, 6 and 12 months after ProstatectomyPad use
Postoperative complicationsFirst 12 months after Prostatectomy
postoperative PSA12 months

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026